🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This Phase IV study is an a multi-centre, randomised open label, two way cr...
Status
Completed
Location
GSK Investigational Site
Start Date
2014-11-14
Trial ID
NCT02233803
The purpose of this study is to compare the test product Budesonide/formote...
Status
Completed
Location
Orion Pharma Phase I Unit
Start Date
2011-07
Trial ID
NCT01386996
Treatments Being Tested
This is a randomized, placebo-controlled, 2-period crossover, escalating re...
Status
Completed
Location
GSK Investigational Site
Start Date
2017-02-09
Trial ID
NCT02991859
The purpose of this study is to determine whether Symbicort dosed according...
Status
Completed
Location
Research Site
Start Date
2004-12
Trial ID
NCT00252863
Treatments Being Tested
The purpose of this study is to investigate the effect of combined treatmen...
Status
Completed
Location
Research Site
Start Date
2007-05
Trial ID
NCT00496470
Treatments Being Tested
To compare the efficacy of combination therapy of montelukast plus low dose...
Status
Completed
Location
Ajou University Medical Center
Start Date
2010-07
Trial ID
NCT01147510
Treatments Being Tested
The purpose of the this study is to evaluate the efficacy and safety of 2 a...
Status
Completed
Location
Research Site
Start Date
2007-09
Trial ID
NCT00536731
Treatments Being Tested
To assess the effect of up to 4 years treatment with budesonide on progress...
Status
Completed
Location
Research Site
Start Date
1999-07
Trial ID
NCT00232674
Treatments Being Tested
A Randomized, Double-Blind, Parallel Group, 28-Week Chronic Dosing, Multi-C...
Status
Completed
Location
Research Site
Start Date
2016-08-09
Trial ID
NCT03262012
Treatments Being Tested
The purpose of this study is to compare the test product Budesonide/formote...
Status
Completed
Location
Orion Pharma Clinical Pharmacology Unit
Start Date
2012-05
Trial ID
NCT01593826